Evidence-Based Medicine Guidelines
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for remnant ablation in differentiated thyroid cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Human Thyrotropin (rhTSH) Aided Radioiodine Treatment for Remnant Ablation in Differentiated Thyroid Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457345/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_remnant_ablation_in_differentiated_thyroid_cancer.
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for remnant ablation in differentiated thyroid cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457345/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_remnant_ablation_in_differentiated_thyroid_cancer. Accessed May 28, 2023.
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for remnant ablation in differentiated thyroid cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457345/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_remnant_ablation_in_differentiated_thyroid_cancer
Recombinant Human Thyrotropin (rhTSH) Aided Radioiodine Treatment for Remnant Ablation in Differentiated Thyroid Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 May 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457345/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_remnant_ablation_in_differentiated_thyroid_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for remnant ablation in differentiated thyroid cancer
ID - 457345
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457345/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_remnant_ablation_in_differentiated_thyroid_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
